Kenneth R Conner1, Jaclyn C Kearns2, Erika C Esposito3, Edmund Pizzarello4, Timothy J Wiegand4, Peter C Britton5, Konrad Michel6, Anja C Gysin-Maillart7, David B Goldston8. 1. University of Rochester Medical Center, Rochester, NY, USA. Electronic address: kenneth_conner@urmc.rochester.edu. 2. Department of Psychology, University of Rochester, Rochester, NY, USA. Electronic address: jaclyn.kearns@rochester.edu. 3. Department of Psychology, University of Rochester, Rochester, NY, USA. 4. University of Rochester Medical Center, Rochester, NY, USA. 5. University of Rochester Medical Center, Rochester, NY, USA; Center of Excellence for Suicide Prevention, Finger Lakes VA Healthcare System, Canandaigua, NY, USA. 6. University Hospital of Psychiatry, Bern, Switzerland. 7. Translational Research Centre, University Hospital of Psychiatry, University of Bern, Switzerland; Unit for Clinical Suicide Research, Department of Clinical Sciences, Psychiatry, Faculty of Medicine, Lund University, Sweden; University of Leipzig, Department of Medical Psychology and Medical Sociology, Germany. 8. Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Abstract
OBJECTIVE: The Attempted Suicide Short Intervention Program (ASSIP) was adapted for hospital delivery and to address substance use problems as well as evaluated for feasibility, acceptability, and therapist fidelity in a series of preparatory steps (n = 28) and in a pilot randomized controlled trial, RCT (n = 34). METHOD: In the RCT, patients with suicide attempts and substance use problem(s) with sufficient lengths of stay to deliver three ASSIP therapy sessions in hospital were randomized to adapted ASSIP or treatment as usual control. A blinded assessor identified suicide reattempts over 6-month follow-up with the Columbia-Suicide Severity Rating Scale (C-SSRS) and a comprehensive multi-source method. Treatment process measures and the Scale for Suicidal Ideation (SSI) were also administered. RESULTS: Median hospital stay was 13 days. ASSIP subjects reported high satisfaction with the treatment and high therapeutic alliance. Study therapists showed high fidelity to the modified ASSIP intervention. Repetition of suicide attempt was common in both study groups including a combined 9 (26%) subjects with reattempt based on C-SSRS and 13 (38%) subjects with reattempt based on multiple sources. CONCLUSIONS: Adult suicide attempt patients with substance use problems who require lengthy hospitalizations are at exceptionally high risk and may require additional strategies to lower risk.
OBJECTIVE: The Attempted Suicide Short Intervention Program (ASSIP) was adapted for hospital delivery and to address substance use problems as well as evaluated for feasibility, acceptability, and therapist fidelity in a series of preparatory steps (n = 28) and in a pilot randomized controlled trial, RCT (n = 34). METHOD: In the RCT, patients with suicide attempts and substance use problem(s) with sufficient lengths of stay to deliver three ASSIP therapy sessions in hospital were randomized to adapted ASSIP or treatment as usual control. A blinded assessor identified suicide reattempts over 6-month follow-up with the Columbia-Suicide Severity Rating Scale (C-SSRS) and a comprehensive multi-source method. Treatment process measures and the Scale for Suicidal Ideation (SSI) were also administered. RESULTS: Median hospital stay was 13 days. ASSIP subjects reported high satisfaction with the treatment and high therapeutic alliance. Study therapists showed high fidelity to the modified ASSIP intervention. Repetition of suicide attempt was common in both study groups including a combined 9 (26%) subjects with reattempt based on C-SSRS and 13 (38%) subjects with reattempt based on multiple sources. CONCLUSIONS: Adult suicide attempt patients with substance use problems who require lengthy hospitalizations are at exceptionally high risk and may require additional strategies to lower risk.
Authors: Kelly Posner; Gregory K Brown; Barbara Stanley; David A Brent; Kseniya V Yershova; Maria A Oquendo; Glenn W Currier; Glenn A Melvin; Laurence Greenhill; Sa Shen; J John Mann Journal: Am J Psychiatry Date: 2011-12 Impact factor: 18.112
Authors: Richard S Swain; Lockwood G Taylor; Elisa R Braver; Wei Liu; Simone P Pinheiro; Andrew D Mosholder Journal: Int J Epidemiol Date: 2019-10-01 Impact factor: 7.196
Authors: Richard K Ries; Christine Yuodelis-Flores; Katherine Anne Comtois; Peter P Roy-Byrne; Joan E Russo Journal: J Subst Abuse Treat Date: 2007-06-15
Authors: Daniel Thomas Chung; Christopher James Ryan; Dusan Hadzi-Pavlovic; Swaran Preet Singh; Clive Stanton; Matthew Michael Large Journal: JAMA Psychiatry Date: 2017-07-01 Impact factor: 21.596